Optimizing the Direct Amplification of Missing cDNA 5' Ends,,, Using the Eppendorf Mastercycler gradient ( ...)

Optimizing the Direct Amplification of Missing cDNA 5' Ends,,, Using the Eppendorf Mastercycler gradient

Bibliography

Ohara, O., Dorit, R., and Gilbert, W. (1989) One-sided polymerase chain reaction: the amplification of cDNA. Proc. Natl. Acad. USA 86, 5673-5677.
Frohman, M. A., Dush, M. K., and Martin, G. R. (1988) Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer. Proc. Natl. Acad. USA 85, 998-1002.
Moreau, A., Duez, C., and Dusart, J. (1994) Improvement of GC-rich template amplification by inverse PCR. BioTechniques 17, 233-234.
Schuchard, M., Sarkar, G., Ruesink, T., and Spelsberg, T. C. (1993) Two-step hot PCR amplification of GC-rich avian c-myc sequences. BioTechniques 14, 390-394.

Source:

Page: All 1 2 3 4 5
Related biology technology :

1. Optimizing Transfection Conditions for Studying Signal Transduction Pathways
2. Optimizing pfuturbo DNA Polymerase Amplification Reactions with Perfect Match PCR Enhancer
3. Optimizing electroporation parameters
4. Optimizing Büchi® Rotary Evaporator Applications
5. Optimizing electroporation parameters
6. Optimizing Büchi® Rotary Evaporator Applications
7. Optimizing Bchi Rotary Evaporator Applications
8. Optimizing electroporation parameters
9. Optimizing electroporation parameters
10. Optimizing electroporation parameters
11. Optimizing electroporation parameters

Post Your Comments:

(Date:11/9/2009)...ollowing the provision of clinical,and scientific ... privately,owned UK company Daval International Li...en informed that its innovative,anti-inflammatory ...esignation for the treatment of Amyotrophic Latera...ou Gehrig,s disease, is the most common form of Mo...

(Date:11/6/2009)...Call/ -- BioSpecifics Technologies Corp. (Nasdaq: ...rst-in-class collagenase-based products, today ann... ended September 30, 2009. ,, "We were extreme...s Arthritis Advisory Committee unanimously recomme...M) for the treatment of Dupuytren,s disease, and w...

(Date:11/6/2009)...e/ -- Calbiotech, Inc. announced today that it has... (SBIR) Phase I contract by the U.S. Army Medical ...agreement, Calbiotech will develop analyte specifi...s. ,, Dengue virus is a mosquito-born flaviv...rces deployed to tropical areas of the world. Due ...

(Date:11/5/2009)...rstCall/ -- GenVec, Inc. (Nasdaq: GNVC ) today an...r ended September 30, 2009. GenVec reported a net ...ee months ended September 30, 2009 compared to a n...omparable quarter of 2008. For the nine months end... million ($0.15 per share), compared to a net loss...

[0] Daval International Awarded Orphan Drug Designation for Motor Neurone Disease Treatment [0] Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results [0] Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus [0] GenVec Reports Third Quarter 2009 Financial Results

...isition Creates Expanded Biodefense Pipeline, ANN...x: PIP ) a biodefense company specializing in the...termeasures against biological and,chemical threat...sition of,Avecia,s biodefense vaccines business pr...ight, President and Chief Executive Officer, comme...

...2, 2008 PAREXEL International,Corporation (Nasdaq...ices,organization, today announced that Larry Eres...bouj, M.D., have been appointed as Vice Presidents...he Company,s international,clinical pharmacology b...arly phase clinical development in the central ner...

...inia and ROSH HAAYIN, Israel, April 2 The,Virgini...ntly announced the,newest company to establish the...rch Park as a member of the VBCC program, EnzySurg...c wound management., "EnzySurge has developed Der...treaming Therapy(TM) (CST) technology. DermaStream...

Other Biology Technology:PharmAthene Closes Acquisition of Avecia Biodefense Vaccines Business Unit 2 PharmAthene Closes Acquisition of Avecia Biodefense Vaccines Business Unit 3 PharmAthene Closes Acquisition of Avecia Biodefense Vaccines Business Unit 4 PharmAthene Closes Acquisition of Avecia Biodefense Vaccines Business Unit 5 PAREXEL Appoints Leading Central Nervous System Experts to Its Global Clinical Pharmacology Business 2 PAREXEL Appoints Leading Central Nervous System Experts to Its Global Clinical Pharmacology Business 3 PAREXEL Appoints Leading Central Nervous System Experts to Its Global Clinical Pharmacology Business 4 PAREXEL Appoints Leading Central Nervous System Experts to Its Global Clinical Pharmacology Business 5 EnzySurge, Maker of DermaStream(TM), Establishes a US Office in the Virginia Biotech Commercialization Center 2 EnzySurge, Maker of DermaStream(TM), Establishes a US Office in the Virginia Biotech Commercialization Center 3

PharmAthene Closes Acquisition of Avecia Biodefense Vaccines Business Unit PAREXEL Appoints Leading Central Nervous System Experts to Its Global Clinical Pharmacology Business EnzySurge, Maker of DermaStream(TM), Establishes a US Office in the Virginia Biotech Commercialization Center

(Date:11/9/2009)... government and industry researchers has completed...genome. The project is an important first step in ...nce crop and addressing some of the many limitatio... Cassava is a root crop that serves as the primary... day. Although it has many properties that make it...

(Date:11/9/2009)...t responsible for the rapid, mysterious death of p...found by collaborating scientists at Rutgers Unive... (WHOI). This same chemical may hold unexpected p... a previously unknown lipid, or fatty compound, in...iania huxleyi , a phytoplankton that plays a major...

(Date:11/8/2009)...8, 2009) The loss of a gene through deletion of g...h significant abnormalities in learning and behavi... College of Medicine ( www.bcm.edu ) in a report t...netics . , "This research goes about 95 percent ... group of individuals to this gene," said Dr. Arth...

Breaking Biology News(10 mins):Researchers complete draft genome sequence for cassava 2 Researchers complete draft genome sequence for cassava 3 Researchers complete draft genome sequence for cassava 4 Newly discovered fat molecule: An undersea killer with an upside 2 Newly discovered fat molecule: An undersea killer with an upside 3 Newly discovered fat molecule: An undersea killer with an upside 4 Developmental delay could stem from nicotinic receptor deletion 2 Pergamum to Provide Effective Development of Innovative Dermatology and Wound Healing Companies 13974 1 Pergamum to Provide Effective Development of Innovative Dermatology and Wound Healing Companies 13974 2 Girl in Iconic Vietnam War Photo Brings Message of Hope 56745 1 Girl in Iconic Vietnam War Photo Brings Message of Hope 56745 2 Girl in Iconic Vietnam War Photo Brings Message of Hope 56745 3 Girl in Iconic Vietnam War Photo Brings Message of Hope 56745 4 QuatRx Announces Positive Results of Second Pivotal Phase 3 Clinical Study for Ophena 28TM 29 28Ospemifene Tablets 29 in Treatment of Postmenopausal 56740 1 QuatRx Announces Positive Results of Second Pivotal Phase 3 Clinical Study for Ophena 28TM 29 28Ospemifene Tablets 29 in Treatment of Postmenopausal 56740 2 QuatRx Announces Positive Results of Second Pivotal Phase 3 Clinical Study for Ophena 28TM 29 28Ospemifene Tablets 29 in Treatment of Postmenopausal 56740 3 QuatRx Announces Positive Results of Second Pivotal Phase 3 Clinical Study for Ophena 28TM 29 28Ospemifene Tablets 29 in Treatment of Postmenopausal 56740 4

[0] Researchers complete draft genome sequence for cassava [0] Newly discovered fat molecule: An undersea killer with an upside [0] Developmental delay could stem from nicotinic receptor deletion

...ences on health and disease has begun to shed ligh...rate different characteristics, such as susceptibi...nmental exposure to nutritional, chemical and phys...aning above the genome, the epigenome refers to di...thout changing the sequence of DNA. , An article...

... Board has funded Washington Universitys Internati...ainability (I-CARES) nearly $3 million for biofuel...orate with others at Saint Louis University, the U... Louis and the Donald Danforth Plant Science Cente...ablishing alternative sources of fuel as well as r...

...vices does not involve the same rigorous review us...n order to improve health outcomes, say researcher.... , The UCSF team analyzes the problem and prop...icle in the January 2008 issue of the Journal of G...al devices. UCSF researchers Mitchell D. Feldman,...

Other Biology News:Environmental epigenetics has potential for preventing and treating disease 2 Environmental epigenetics has potential for preventing and treating disease 3 Missouri board grants Washington University Sustainability Center $3 million 2 Analysis calls for medical device information to better serve patients and doctors 2 Analysis calls for medical device information to better serve patients and doctors 3

Environmental epigenetics has potential for preventing and treating disease Missouri board grants Washington University Sustainability Center $3 million Analysis calls for medical device information to better serve patients and doctors

Mouse Anti-Human FACTOR I Monoclonal Antibody, Unconjugated, Clone 3R2/2 from AbD Serotec

Human, Bovine, Porcine, Rat VIP, aa 6-28 from Biotrend Chemikalien GmbH

RAPTOR from Bioinformatics Solutions Inc.

Mouse Anti-L1 Protein of Human Papilloma Virus Monoclonal Antibody, Unconjugated, Clone CAMVIR-1 from BD Biosciences Pharmingen

Biology Products:

Mouse Anti-Human FACTOR I Monoclonal Antibody, Unconjugated, Clone 3R2/2 from AbD Serotec Human, Bovine, Porcine, Rat VIP, aa 6-28 from Biotrend Chemikalien GmbH RAPTOR from Bioinformatics Solutions Inc.Mouse Anti-L1 Protein of Human Papilloma Virus Monoclonal Antibody, Unconjugated, Clone CAMVIR-1 from BD Biosciences Pharmingen

( ...)Optimizing the Direct Amplification of Missing cDNA 5' Ends,,, Using the Eppendorf Mastercycler gradient